Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • fish
    Member
    • Sep 2013
    • 10

    #1

    MiSeq v2 vs. v3 kits - run variation

    Hi,

    last year we sequenced two libraries of fish skin samples for one study, the V4 region of the 16S.
    The first library was sequenced with the v3 kit because it was new and our sequencing service thought it's worth a try. However, for V4 I actually don't need the v3 kit since the amplicon is ~ 250 bp long. I received ok sequences but later had problems with an increase of unique sequences in the analysis pipeline, a well known problem very nicely described by Pat Schloss: http://blog.mothur.org/2014/09/11/Wh...nce-matrix%3F/.
    So we sequenced the second library with the v2 kit and I included 15 samples from library 1 in there, to be able to correct for run variation. In fact, the 15 technical replicates were very similar in later analysis but when I checked the whole data set of 250 samples, I detected in part a large variation in the data according to the different runs. For instance, when I analyzed alpha-diversity, the factor run had the highest impact on the results, higher than the factors I was interested in.

    Did somebody of you ever had the same problem?
    I'm actually afraid that I can not publish my results because of that issue.

    Thanks!
  • thermophile
    Senior Member
    • Apr 2015
    • 243

    #2
    Were different parts of the experiment run on both or were controls all run first then treatment later? If you compare the 15 repeated samples with something like partial-mantel, how similar are they?
    Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

    Comment

    • fish
      Member
      • Sep 2013
      • 10

      #3
      Hi,

      I tried to distribute the respective groups of interest I wanted to compare evenly between both runs. The 15 replicates were run with the other samples, I had two runs in total. Did that answer your question?

      I'm not sure what how you would apply with the mantel test, because I would need a second dissimilarity matrix to calculate the correlation, besides Bray Curtis distance or so of the OTUs of the 15 replicates. Maybe you can give me a hint.

      Comment

      • thermophile
        Senior Member
        • Apr 2015
        • 243

        #4
        you'd cluster all of your samples into a giant OTU table, calculate your dissimilarity matrices not for each sample individually but on each treatment type on each run. Then do partial mantel comparing all the treatments on run1 to all the treatments on run2. you're hoping for non-significance
        Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
          by SEQadmin2




          NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
          Today, 06:46 AM
        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-28-2026, 09:57 AM
        0 responses
        22 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-28-2026, 09:51 AM
        0 responses
        14 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        68 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        48 views
        0 reactions
        Last Post SEQadmin2  
        Working...